La bourse est fermée
  • Dow Jones

    27 463,19
    -222,19 (-0,80 %)
     
  • Nasdaq

    11 431,35
    +72,41 (+0,64 %)
     
  • Nikkei 225

    23 485,80
    -8,54 (-0,04 %)
     
  • EUR/USD

    1,1799
    -0,0014 (-0,12 %)
     
  • HANG SENG

    24 787,19
    -131,59 (-0,53 %)
     
  • BTC-EUR

    11 554,29
    +454,94 (+4,10 %)
     
  • CMC Crypto 200

    269,84
    +8,55 (+3,27 %)
     
  • S&P 500

    3 390,68
    -10,29 (-0,30 %)
     

Global Respiratory Disease Testing Industry

ReportLinker
·24 min de lecture

Global Respiratory Disease Testing Market to Reach $3. 3 Billion by 2027. Amid the COVID-19 crisis, the global market for Respiratory Disease Testing estimated at US$2. 8 Billion in the year 2020, is projected to reach a revised size of US$3.

New York, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Respiratory Disease Testing Industry" - https://www.reportlinker.com/p05959891/?utm_source=GNW
3 Billion by 2027, growing at a CAGR of 2.2% over the analysis period 2020-2027. Imaging, one of the segments analyzed in the report, is projected to record a 2.4% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Spirometry segment is readjusted to a revised 2.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $756.9 Million, While China is Forecast to Grow at 4.3% CAGR

The Respiratory Disease Testing market in the U.S. is estimated at US$756.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$643.6 Million by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.4% and 1.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1% CAGR.

Blood Gas Segment to Record 1.6% CAGR

In the global Blood Gas segment, USA, Canada, Japan, China and Europe will drive the 1.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$167.3 Million in the year 2020 will reach a projected size of US$183 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$441.7 Million by the year 2027, while Latin America will expand at a 2% CAGR through the analysis period. We bring years of research experience to this 9th edition of our report. The 283-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories

  • Affymetrix, Inc.

  • Alere, Inc.

  • CareFusion Corporation

  • Carestream Health, Inc.

  • Cepheid, Inc.

  • Cosmed Srl

  • F. Hoffmann-La Roche AG

  • GE Healthcare

  • Medtronic PLC

  • MGC Diagnostics Corporation

  • ndd Medizintechnik AG

  • Nihon Kohden Corporation

  • PerkinElmer, Inc.

  • Philips Healthcare

  • SDI Diagnostics

  • Seegene, Inc.

  • Siemens Healthineers

  • Smiths Medical




Read the full report: https://www.reportlinker.com/p05959891/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Respiratory Disease Testing Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Respiratory Disease Testing Global Market Estimates
and Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Respiratory Disease Testing Global Retrospective
Market Scenario in US$ Million by Region/Country: 2012-2019

Table 3: Respiratory Disease Testing Market Share Shift across
Key Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Imaging (Test Type) World Market by Region/Country in
US$ Million: 2020 to 2027

Table 5: Imaging (Test Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019

Table 6: Imaging (Test Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: Spirometry (Test Type) Potential Growth Markets
Worldwide in US$ Million: 2020 to 2027

Table 8: Spirometry (Test Type) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019

Table 9: Spirometry (Test Type) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 10: Blood Gas (Test Type) Geographic Market Spread
Worldwide in US$ Million: 2020 to 2027

Table 11: Blood Gas (Test Type) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2012 to 2019

Table 12: Blood Gas (Test Type) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 13: Other Test Types (Test Type) World Market Estimates
and Forecasts by Region/Country in US$ Million: 2020 to 2027

Table 14: Other Test Types (Test Type) Market Historic Review
by Region/Country in US$ Million: 2012 to 2019

Table 15: Other Test Types (Test Type) Market Share Breakdown
by Region/Country: 2012 VS 2020 VS 2027

Table 16: Hospitals (End-Use) Worldwide Latent Demand Forecasts
in US$ Million by Region/Country: 2020-2027

Table 17: Hospitals (End-Use) Global Historic Analysis in US$
Million by Region/Country: 2012-2019

Table 18: Hospitals (End-Use) Distribution of Global Sales by
Region/Country: 2012 VS 2020 VS 2027

Table 19: Clinical Laboratories (End-Use) Sales Estimates and
Forecasts in US$ Million by Region/Country for the Years 2020
through 2027

Table 20: Clinical Laboratories (End-Use) Analysis of Historic
Sales in US$ Million by Region/Country for the Years 2012 to
2019

Table 21: Clinical Laboratories (End-Use) Global Market Share
Distribution by Region/Country for 2012, 2020, and 2027

Table 22: Physician Offices (End-Use) Global Opportunity
Assessment in US$ Million by Region/Country: 2020-2027

Table 23: Physician Offices (End-Use) Historic Sales Analysis
in US$ Million by Region/Country: 2012-2019

Table 24: Physician Offices (End-Use) Percentage Share
Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Respiratory Disease Testing Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 25: United States Respiratory Disease Testing Market
Estimates and Projections in US$ Million by Test Type: 2020 to
2027

Table 26: Respiratory Disease Testing Market in the United
States by Test Type: A Historic Review in US$ Million for
2012-2019

Table 27: United States Respiratory Disease Testing Market
Share Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 28: United States Respiratory Disease Testing Latent
Demand Forecasts in US$ Million by End-Use: 2020 to 2027

Table 29: Respiratory Disease Testing Historic Demand Patterns
in the United States by End-Use in US$ Million for 2012-2019

Table 30: Respiratory Disease Testing Market Share Breakdown in
the United States by End-Use: 2012 VS 2020 VS 2027

CANADA
Table 31: Canadian Respiratory Disease Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020 to 2027

Table 32: Canadian Respiratory Disease Testing Historic Market
Review by Test Type in US$ Million: 2012-2019

Table 33: Respiratory Disease Testing Market in Canada:
Percentage Share Breakdown of Sales by Test Type for 2012,
2020, and 2027

Table 34: Canadian Respiratory Disease Testing Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 35: Respiratory Disease Testing Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 36: Canadian Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

JAPAN
Table 37: Japanese Market for Respiratory Disease Testing:
Annual Sales Estimates and Projections in US$ Million by Test
Type for the Period 2020-2027

Table 38: Respiratory Disease Testing Market in Japan: Historic
Sales Analysis in US$ Million by Test Type for the Period
2012-2019

Table 39: Japanese Respiratory Disease Testing Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027

Table 40: Japanese Demand Estimates and Forecasts for
Respiratory Disease Testing in US$ Million by End-Use: 2020 to
2027

Table 41: Japanese Respiratory Disease Testing Market in US$
Million by End-Use: 2012-2019

Table 42: Respiratory Disease Testing Market Share Shift in
Japan by End-Use: 2012 VS 2020 VS 2027

CHINA
Table 43: Chinese Respiratory Disease Testing Market Growth
Prospects in US$ Million by Test Type for the Period 2020-2027

Table 44: Respiratory Disease Testing Historic Market Analysis
in China in US$ Million by Test Type: 2012-2019

Table 45: Chinese Respiratory Disease Testing Market by Test
Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 46: Chinese Demand for Respiratory Disease Testing in US$
Million by End-Use: 2020 to 2027

Table 47: Respiratory Disease Testing Market Review in China in
US$ Million by End-Use: 2012-2019

Table 48: Chinese Respiratory Disease Testing Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027

EUROPE
Market Facts & Figures
European Respiratory Disease Testing Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 49: European Respiratory Disease Testing Market Demand
Scenario in US$ Million by Region/Country: 2020-2027

Table 50: Respiratory Disease Testing Market in Europe:
A Historic Market Perspective in US$ Million by Region/Country
for the Period 2012-2019

Table 51: European Respiratory Disease Testing Market Share
Shift by Region/Country: 2012 VS 2020 VS 2027

Table 52: European Respiratory Disease Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020-2027

Table 53: Respiratory Disease Testing Market in Europe in US$
Million by Test Type: A Historic Review for the Period
2012-2019

Table 54: European Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 55: European Respiratory Disease Testing Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 56: Respiratory Disease Testing Market in Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 57: European Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

FRANCE
Table 58: Respiratory Disease Testing Market in France by Test
Type: Estimates and Projections in US$ Million for the Period
2020-2027

Table 59: French Respiratory Disease Testing Historic Market
Scenario in US$ Million by Test Type: 2012-2019

Table 60: French Respiratory Disease Testing Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027

Table 61: Respiratory Disease Testing Quantitative Demand
Analysis in France in US$ Million by End-Use: 2020-2027

Table 62: French Respiratory Disease Testing Historic Market
Review in US$ Million by End-Use: 2012-2019

Table 63: French Respiratory Disease Testing Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027

GERMANY
Table 64: Respiratory Disease Testing Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Test Type
for the Period 2020-2027

Table 65: German Respiratory Disease Testing Historic Market
Analysis in US$ Million by Test Type: 2012-2019

Table 66: German Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 67: Respiratory Disease Testing Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 68: German Respiratory Disease Testing Market in
Retrospect in US$ Million by End-Use: 2012-2019

Table 69: Respiratory Disease Testing Market Share Distribution
in Germany by End-Use: 2012 VS 2020 VS 2027

ITALY
Table 70: Italian Respiratory Disease Testing Market Growth
Prospects in US$ Million by Test Type for the Period 2020-2027

Table 71: Respiratory Disease Testing Historic Market Analysis
in Italy in US$ Million by Test Type: 2012-2019

Table 72: Italian Respiratory Disease Testing Market by Test
Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 73: Italian Demand for Respiratory Disease Testing in US$
Million by End-Use: 2020 to 2027

Table 74: Respiratory Disease Testing Market Review in Italy in
US$ Million by End-Use: 2012-2019

Table 75: Italian Respiratory Disease Testing Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027

UNITED KINGDOM
Table 76: United Kingdom Market for Respiratory Disease
Testing: Annual Sales Estimates and Projections in US$ Million
by Test Type for the Period 2020-2027

Table 77: Respiratory Disease Testing Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Test Type
for the Period 2012-2019

Table 78: United Kingdom Respiratory Disease Testing Market
Share Analysis by Test Type: 2012 VS 2020 VS 2027

Table 79: United Kingdom Demand Estimates and Forecasts for
Respiratory Disease Testing in US$ Million by End-Use: 2020 to
2027

Table 80: United Kingdom Respiratory Disease Testing Market in
US$ Million by End-Use: 2012-2019

Table 81: Respiratory Disease Testing Market Share Shift in the
United Kingdom by End-Use: 2012 VS 2020 VS 2027

SPAIN
Table 82: Spanish Respiratory Disease Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020 to 2027

Table 83: Spanish Respiratory Disease Testing Historic Market
Review by Test Type in US$ Million: 2012-2019

Table 84: Respiratory Disease Testing Market in Spain:
Percentage Share Breakdown of Sales by Test Type for 2012,
2020, and 2027

Table 85: Spanish Respiratory Disease Testing Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 86: Respiratory Disease Testing Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 87: Spanish Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

RUSSIA
Table 88: Russian Respiratory Disease Testing Market Estimates
and Projections in US$ Million by Test Type: 2020 to 2027

Table 89: Respiratory Disease Testing Market in Russia by Test
Type: A Historic Review in US$ Million for 2012-2019

Table 90: Russian Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 91: Russian Respiratory Disease Testing Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 92: Respiratory Disease Testing Historic Demand Patterns
in Russia by End-Use in US$ Million for 2012-2019

Table 93: Respiratory Disease Testing Market Share Breakdown in
Russia by End-Use: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 94: Rest of Europe Respiratory Disease Testing Market
Estimates and Forecasts in US$ Million by Test Type: 2020-2027

Table 95: Respiratory Disease Testing Market in Rest of Europe
in US$ Million by Test Type: A Historic Review for the Period
2012-2019

Table 96: Rest of Europe Respiratory Disease Testing Market
Share Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 97: Rest of Europe Respiratory Disease Testing
Addressable Market Opportunity in US$ Million by End-Use:
2020-2027

Table 98: Respiratory Disease Testing Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 99: Rest of Europe Respiratory Disease Testing Market
Share Analysis by End-Use: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 100: Asia-Pacific Respiratory Disease Testing Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 101: Respiratory Disease Testing Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2012-2019

Table 102: Asia-Pacific Respiratory Disease Testing Market
Share Analysis by Region/Country: 2012 VS 2020 VS 2027

Table 103: Respiratory Disease Testing Market in Asia-Pacific
by Test Type: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 104: Asia-Pacific Respiratory Disease Testing Historic
Market Scenario in US$ Million by Test Type: 2012-2019

Table 105: Asia-Pacific Respiratory Disease Testing Market
Share Analysis by Test Type: 2012 VS 2020 VS 2027

Table 106: Respiratory Disease Testing Quantitative Demand
Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027

Table 107: Asia-Pacific Respiratory Disease Testing Historic
Market Review in US$ Million by End-Use: 2012-2019

Table 108: Asia-Pacific Respiratory Disease Testing Market
Share Analysis: A 17-Year Perspectiveby End-Use for 2012, 2020,
and 2027

AUSTRALIA
Table 109: Respiratory Disease Testing Market in Australia:
Recent Past, Current and Future Analysis in US$ Million by Test
Type for the Period 2020-2027

Table 110: Australian Respiratory Disease Testing Historic
Market Analysis in US$ Million by Test Type: 2012-2019

Table 111: Australian Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 112: Respiratory Disease Testing Market in Australia:
Annual Sales Estimates and Forecasts in US$ Million by End-Use
for the Period 2020-2027

Table 113: Australian Respiratory Disease Testing Market in
Retrospect in US$ Million by End-Use: 2012-2019

Table 114: Respiratory Disease Testing Market Share
Distribution in Australia by End-Use: 2012 VS 2020 VS 2027

INDIA
Table 115: Indian Respiratory Disease Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020 to 2027

Table 116: Indian Respiratory Disease Testing Historic Market
Review by Test Type in US$ Million: 2012-2019

Table 117: Respiratory Disease Testing Market in India:
Percentage Share Breakdown of Sales by Test Type for 2012,
2020, and 2027

Table 118: Indian Respiratory Disease Testing Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 119: Respiratory Disease Testing Market in India:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 120: Indian Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

SOUTH KOREA
Table 121: Respiratory Disease Testing Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by Test
Type for the Period 2020-2027

Table 122: South Korean Respiratory Disease Testing Historic
Market Analysis in US$ Million by Test Type: 2012-2019

Table 123: Respiratory Disease Testing Market Share
Distribution in South Korea by Test Type: 2012 VS 2020 VS 2027

Table 124: Respiratory Disease Testing Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
End-Use for the Period 2020-2027

Table 125: South Korean Respiratory Disease Testing Historic
Market Analysis in US$ Million by End-Use: 2012-2019

Table 126: Respiratory Disease Testing Market Share
Distribution in South Korea by End-Use: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 127: Rest of Asia-Pacific Market for Respiratory Disease
Testing: Annual Sales Estimates and Projections in US$ Million
by Test Type for the Period 2020-2027

Table 128: Respiratory Disease Testing Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Test
Type for the Period 2012-2019

Table 129: Rest of Asia-Pacific Respiratory Disease Testing
Market Share Analysis by Test Type: 2012 VS 2020 VS 2027

Table 130: Rest of Asia-Pacific Demand Estimates and Forecasts
for Respiratory Disease Testing in US$ Million by End-Use: 2020
to 2027

Table 131: Rest of Asia-Pacific Respiratory Disease Testing
Market in US$ Million by End-Use: 2012-2019

Table 132: Respiratory Disease Testing Market Share Shift in
Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027

LATIN AMERICA
Table 133: Latin American Respiratory Disease Testing Market
Trends by Region/Country in US$ Million: 2020-2027

Table 134: Respiratory Disease Testing Market in Latin America
in US$ Million by Region/Country: A Historic Perspective for
the Period 2012-2019

Table 135: Latin American Respiratory Disease Testing Market
Percentage Breakdown of Sales by Region/Country: 2012, 2020,
and 2027

Table 136: Latin American Respiratory Disease Testing Market
Growth Prospects in US$ Million by Test Type for the Period
2020-2027

Table 137: Respiratory Disease Testing Historic Market Analysis
in Latin America in US$ Million by Test Type: 2012-2019

Table 138: Latin American Respiratory Disease Testing Marketby
Test Type: Percentage Breakdown of Sales for 2012, 2020, and
2027

Table 139: Latin American Demand for Respiratory Disease
Testing in US$ Million by End-Use: 2020 to 2027

Table 140: Respiratory Disease Testing Market Review in Latin
America in US$ Million by End-Use: 2012-2019

Table 141: Latin American Respiratory Disease Testing Market
Share Breakdown by End-Use: 2012 VS 2020 VS 2027

ARGENTINA
Table 142: Argentinean Respiratory Disease Testing Market
Estimates and Forecasts in US$ Million by Test Type: 2020-2027

Table 143: Respiratory Disease Testing Market in Argentina in
US$ Million by Test Type: A Historic Review for the Period
2012-2019

Table 144: Argentinean Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 145: Argentinean Respiratory Disease Testing Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 146: Respiratory Disease Testing Market in Argentina:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 147: Argentinean Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

BRAZIL
Table 148: Respiratory Disease Testing Market in Brazil by Test
Type: Estimates and Projections in US$ Million for the Period
2020-2027

Table 149: Brazilian Respiratory Disease Testing Historic
Market Scenario in US$ Million by Test Type: 2012-2019

Table 150: Brazilian Respiratory Disease Testing Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027

Table 151: Respiratory Disease Testing Quantitative Demand
Analysis in Brazil in US$ Million by End-Use: 2020-2027

Table 152: Brazilian Respiratory Disease Testing Historic
Market Review in US$ Million by End-Use: 2012-2019

Table 153: Brazilian Respiratory Disease Testing Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027

MEXICO
Table 154: Respiratory Disease Testing Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Test Type
for the Period 2020-2027

Table 155: Mexican Respiratory Disease Testing Historic Market
Analysis in US$ Million by Test Type: 2012-2019

Table 156: Mexican Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 157: Respiratory Disease Testing Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 158: Mexican Respiratory Disease Testing Market in
Retrospect in US$ Million by End-Use: 2012-2019

Table 159: Respiratory Disease Testing Market Share
Distribution in Mexico by End-Use: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 160: Rest of Latin America Respiratory Disease Testing
Market Estimates and Projections in US$ Million by Test Type:
2020 to 2027

Table 161: Respiratory Disease Testing Market in Rest of Latin
America by Test Type: A Historic Review in US$ Million for
2012-2019

Table 162: Rest of Latin America Respiratory Disease Testing
Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 163: Rest of Latin America Respiratory Disease Testing
Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027

Table 164: Respiratory Disease Testing Historic Demand Patterns
in Rest of Latin America by End-Use in US$ Million for
2012-2019

Table 165: Respiratory Disease Testing Market Share Breakdown
in Rest of Latin America by End-Use: 2012 VS 2020 VS 2027

MIDDLE EAST
Table 166: The Middle East Respiratory Disease Testing Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 167: Respiratory Disease Testing Market in the Middle
East by Region/Country in US$ Million: 2012-2019

Table 168: The Middle East Respiratory Disease Testing Market
Share Breakdown by Region/Country: 2012, 2020, and 2027

Table 169: The Middle East Respiratory Disease Testing Market
Estimates and Forecasts in US$ Million by Test Type: 2020 to
2027

Table 170: The Middle East Respiratory Disease Testing Historic
Marketby Test Type in US$ Million: 2012-2019

Table 171: Respiratory Disease Testing Market in the Middle
East: Percentage Share Breakdown of Salesby Test Type for
2012,2020, and 2027

Table 172: The Middle East Respiratory Disease Testing Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 173: Respiratory Disease Testing Market in the Middle
East: Summarization of Historic Demand Patterns in US$ Million
by End-Use for 2012-2019

Table 174: The Middle East Respiratory Disease Testing Market
Share Analysis by End-Use: 2012 VS 2020 VS 2027

IRAN
Table 175: Iranian Market for Respiratory Disease Testing:
Annual Sales Estimates and Projections in US$ Million by Test
Type for the Period 2020-2027

Table 176: Respiratory Disease Testing Market in Iran: Historic
Sales Analysis in US$ Million by Test Type for the Period
2012-2019

Table 177: Iranian Respiratory Disease Testing Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027

Table 178: Iranian Demand Estimates and Forecasts for
Respiratory Disease Testing in US$ Million by End-Use: 2020 to
2027

Table 179: Iranian Respiratory Disease Testing Market in US$
Million by End-Use: 2012-2019

Table 180: Respiratory Disease Testing Market Share Shift in
Iran by End-Use: 2012 VS 2020 VS 2027

ISRAEL
Table 181: Israeli Respiratory Disease Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020-2027

Table 182: Respiratory Disease Testing Market in Israel in US$
Million by Test Type: A Historic Review for the Period
2012-2019

Table 183: Israeli Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 184: Israeli Respiratory Disease Testing Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 185: Respiratory Disease Testing Market in Israel:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 186: Israeli Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

SAUDI ARABIA
Table 187: Saudi Arabian Respiratory Disease Testing Market
Growth Prospects in US$ Million by Test Type for the Period
2020-2027

Table 188: Respiratory Disease Testing Historic Market Analysis
in Saudi Arabia in US$ Million by Test Type: 2012-2019

Table 189: Saudi Arabian Respiratory Disease Testing Market by
Test Type: Percentage Breakdown of Sales for 2012, 2020, and
2027

Table 190: Saudi Arabian Demand for Respiratory Disease Testing
in US$ Million by End-Use: 2020 to 2027

Table 191: Respiratory Disease Testing Market Review in Saudi
Arabia in US$ Million by End-Use: 2012-2019

Table 192: Saudi Arabian Respiratory Disease Testing Market
Share Breakdown by End-Use: 2012 VS 2020 VS 2027

UNITED ARAB EMIRATES
Table 193: Respiratory Disease Testing Market in the United
Arab Emirates: Recent Past, Current and Future Analysis in US$
Million by Test Type for the Period 2020-2027

Table 194: United Arab Emirates Respiratory Disease Testing
Historic Market Analysis in US$ Million by Test Type: 2012-2019

Table 195: Respiratory Disease Testing Market Share
Distribution in United Arab Emirates by Test Type: 2012 VS 2020
VS 2027

Table 196: Respiratory Disease Testing Market in the United
Arab Emirates: Recent Past, Current and Future Analysis in US$
Million by End-Use for the Period 2020-2027

Table 197: United Arab Emirates Respiratory Disease Testing
Historic Market Analysis in US$ Million by End-Use: 2012-2019

Table 198: Respiratory Disease Testing Market Share
Distribution in United Arab Emirates by End-Use: 2012 VS 2020
VS 2027

REST OF MIDDLE EAST
Table 199: Respiratory Disease Testing Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Test Type for the Period 2020-2027

Table 200: Rest of Middle East Respiratory Disease Testing
Historic Market Analysis in US$ Million by Test Type: 2012-2019

Table 201: Rest of Middle East Respiratory Disease Testing
Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 202: Respiratory Disease Testing Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
End-Use for the Period 2020-2027

Table 203: Rest of Middle East Respiratory Disease Testing
Market in Retrospect in US$ Million by End-Use: 2012-2019

Table 204: Respiratory Disease Testing Market Share
Distribution in Rest of Middle East by End-Use: 2012 VS 2020 VS
2027

AFRICA
Table 205: African Respiratory Disease Testing Market Estimates
and Projections in US$ Million by Test Type: 2020 to 2027

Table 206: Respiratory Disease Testing Market in Africa by Test
Type: A Historic Review in US$ Million for 2012-2019

Table 207: African Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 208: African Respiratory Disease Testing Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 209: Respiratory Disease Testing Historic Demand Patterns
in Africa by End-Use in US$ Million for 2012-2019

Table 210: Respiratory Disease Testing Market Share Breakdown
in Africa by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 43
Read the full report: https://www.reportlinker.com/p05959891/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001